ESR2
| Official symbol: | ESR2 |
| Full name: | estrogen receptor 2 |
| Location: | |
| Also known as: | Erb, NR3A2, ER-beta |
| Entrez ID: | 2100 |
| Ensembl ID: | ENSG00000140009 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 1 |
|
|
| Fusions detected in 1 cancer type(s) |
|
| |
|
|
|
| Functional class: | Nuclear hormone receptor |
| JensenLab PubMed score: | 3765.20 (Percentile rank: 98.96%) |
| PubTator score: | 2681.61 (Percentile rank: 98.82%) |
| Target development/druggability level: | TclinThese targets have activities in DrugCentral (ie. approved drugs) with known mechanism of action. |
| Tractability (small molecule): | Clinical PrecedenceTargets with drugs in phase II or above; Pre-clinical targets |
| Tractability (antibody): | |
